Giant cell arteritis with visual loss following zoledronic acid infusion
- PMID: 24472274
- DOI: 10.1111/1756-185X.12263
Giant cell arteritis with visual loss following zoledronic acid infusion
Abstract
Zoledronic acid is used in the treatment of osteoporosis. Giant cell artertitis may lead to vision loss. We report a case in which vision loss occurred after zoledronic acid infusion.
Keywords: clinical aspects; drug treatment; giant cell arteritis; osteoporosis; zoledronic acid.
© 2013 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical